Navigation Links
Alpha-1 Foundation, AARC Cooperate on Study to Test 5,000 COPD Patients for Alpha-1
Date:12/6/2007

DENVER, Dec. 6 /PRNewswire/ -- Some 5,000 COPD patients will be tested to determine the prevalence of Alpha-1 Antitrypsin Deficiency (Alpha-1) in a study marking a major cooperative effort between the Alpha-1 Foundation and the American Association for Respiratory Care (AARC).

The principal investigator is Robert A. Sandhaus, MD, PhD, of the Division of Pulmonary Medicine, National Jewish Medical and Research Center in Denver. Sandhaus is also the Clinical Director of the Alpha-1 Foundation.

According to Sandhaus, "If the current literature is correct, the study should identify about 50 to 100 individuals who are unaware they have COPD due to Alpha-1. In addition, the study should identify about 300 people who are carrying a single abnormal Alpha-1 gene. All will be counseled about the potential risk to their children and family members."

Sandhaus points to an intriguing possibility. "If this study confirms what much smaller studies have suggested about Alphas hidden in the COPD population, there could be as many as 400,000 individuals in the US who have lung disease due to Alpha-1 and don't know it."

More than 12 million people have been diagnosed with COPD (Chronic Obstructive Pulmonary Disease), an umbrella term that includes emphysema and chronic bronchitis. COPD is the 4th leading cause of death in the United States, and is expected to be the third leading killer by 2020. Alpha-1, sometimes called "genetic COPD," is the most common known genetic risk factor for emphysema.

Sandhaus believes the study will demonstrate the effectiveness of using respiratory therapists to perform significant pulmonary clinical research.

"Respiratory therapists will have a critical role as more genetic factors (in lung, airway and sleep disorders) are identified," said Alpha-1 Foundation President and CEO John W. Walsh. "The expanding role of the RT in supporting the physician will accelerate early detection and access to appropriate
'/>"/>

SOURCE Alpha-1 Foundation
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)...ctober 7 /-,Sosei Group Cor...ctura,Group plc ("Vectura"; LSE: VEC), announce re...acy, safety and tolerability of NVA237 presented a...Society (ERS) in Berlin,Germany. The new data sho...haled long-acting muscarinic antagonist (LAMA), pr...
(Date:10/6/2008)...to the understanding of and possible trea...BILLERICA, Mass., Oct. 6 /- Seahorse ...t ever analytical instrument for the,kinetic measu...oplasmic,glycolysis in cells in a 96 well micropla...ular bioenergetics have been relatively unchanged ...
(Date:10/6/2008)... at The American College of Nutrition ...6 /- New research on the benefits of,...t The American College of,Nutrition (ACN) Annual M...Probiotics in Health and Disease." Scientific expe...ion discussed the potential uses for,probiotics in...
(Date:10/6/2008)...E, Oct. 6 /- Complete,Genomics Inc., ...quencing,company, and the Institute for Systems Bi...onduct populationwide human genome studies., In p...e its proprietary,DNA sequencing technology to seq...hen, once proof-of-concept has been demonstrated, ...
Breaking Medicine Technology:NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 2NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 3NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 4NVA237 Phase II Results Presented at the European Respiratory Society Annual Meeting Show Promising Efficacy and Tolerability With Potentially Faster Onset Than Tiotropium 5Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics 2Seahorse Bioscience Announces the XF96 Extracellular Flux Analyzer for Cellular Bioenergetics 3'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 2'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 3'Friendly' Bacteria Can Benefit Health Throughout the Lifecycle 4Complete Genomics and the Institute for Systems Biology Announce Partnership to Conduct the First Human Genome Population Study 2New study in the journal Sleep finds that catathrenia can be successfully treated with CPAP 8958 1New study in the journal Sleep finds that catathrenia can be successfully treated with CPAP 8958 2New study in the journal Sleep finds that catathrenia can be successfully treated with CPAP 8958 3Journal Sleep 3A A short term dose of zolpidem is an effective treatment for insomnia 8956 1Journal Sleep 3A A short term dose of zolpidem is an effective treatment for insomnia 8956 2Research suggests new treatment suitable for all patients 8954 1Research suggests new treatment suitable for all patients 8954 2Research suggests new treatment suitable for all patients 8954 3Silence may lead to phantom noises misinterpreted as tinnitus 8952 1
(Date:10/7/2008)... Moores Cancer Center at the University of Califor...ave off the relentless march of advanced lung canc...r vaccine. While many vaccines attempt to pump up ...accine, Lucanix, is genetically engineered to also...em-suppressing activities. , The first patients ...
(Date:10/7/2008)...ment of planned bequest comes at stem cell symposi...re/ -- Just over one year,ago, retail pioneer A. A...University of Michigan, to endow a new research in...nting human disease., Today, at the institute,s f... he will bequeath an additional $22 million to the...
(Date:10/7/2008)...0 PEOPLE ACROSS THE NATION HAVE SAID ,I VOTE FOR T...S, Oct. 7 /PRNewswire/ -- To aid and help educate ... positions of presidential candidates,Senators Joh...ancer issues,the Susan G. Komen for the Cure(R) A...ces available on its web site --, http://www.IVote...
(Date:10/7/2008)... Wyndstorm Corporation ( www.wyndstorm.com ) ...ompany, announced a key win with Muve, Inc. ( www....plan program design to promote Muve,s activity-bas...project will ultimately help Muve,s corporate clie...oyees via interactive messaging, rewards programs,...
Breaking Medicine News(10 mins):Health News:Novel Lung Cancer Vaccine Trial Launched at Moores UCSD Cancer Center 2Health News:Alfred Taubman Announces New $22M Gift to U-M 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 2Health News:Susan G. Komen for the Cure(R) Advocacy Alliance Educates Voters, Debate Watchers on McCain/Obama Health Care Agendas 3Health News: 3D Social Media Application Aims to Cut Workplace Obesity : Muve, Inc., Selects Social Media Developer Wyndstorm Corporation to Design Online Promotions for Corporate Wellness Program 2Health News: 3D Social Media Application Aims to Cut Workplace Obesity : Muve, Inc., Selects Social Media Developer Wyndstorm Corporation to Design Online Promotions for Corporate Wellness Program 3
...claim to the highest autism rate in America, have ...to autism and provide lifetime care for those wit...utism, the largest so far, has found that about 1 ...est rate 1 in 94 children found in New Jersey. ...
...tronic nose device which may be used to diagnose t...s at Leiden University Medical Center in the Nethe... a newer version of a sensor that has been used in...es, contains chemical vapour sensors that react to...
...male impotence drug Viagra may be useful for treat...r the treatment of high blood pressure and angina,...levels of a naturally-occurring compound, cyclic g...GMP). In the brain, cGMP has a vital function in ...
...that topical application of a gel made from platel...ds heal more quickly and completely . Recent inno... into a concentrated plasma rich in platelets (par...), and then to an autologous (from the patients ow...
Other Medicine News:Health News:American State Lawmakers Make Moves To Tackle Autism 2Health News:Electronic Nose to Diagnose the Severity of Asthma 2Health News:Gel Made of Patients Own Platelets may Speed Up Wound Healing 2
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
Medicine Products: